P-ISSN 2587-2400 | E-ISSN 2587-196X
The effect of alpha lipoic acid in the treatment of multiple sclerosis induced neuropathic pain: A case report [EJMO]
EJMO. Ahead of Print: EJMO-37929 | DOI: 10.14744/ejmo.2017.37929

The effect of alpha lipoic acid in the treatment of multiple sclerosis induced neuropathic pain: A case report

Fazıl Kulaklı
giresun prof. dr. ilhan özdemir education and research hospital, department of physical medicine and rehabilitation

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) resulting in motor, sensory and cognitive impairment. The symptoms of MS greatly affect the quality of life (QOL) for patients and one of the most common symptom is pain. Neuropathic pain (NP) that develops secondary to demyelination, neuro-inflammation and axonal damage in the CNS is the most distressing and difficult type of pain to treat in patients with MS. A patient with MS presented to our department with dysaesthetic extremity pain characterised by burning and tingling predominantly in the legs bilateral and was worse at night. She was evaluated and diagnosed with MS induced NP and treated with alpha lipoic acid (ALA) because of unresponsiveness and intolerance to amitriptilin, pregabalin and gabapentin treatments. The aim of this report is presenting and discussing the ALA treatment in a patient with MS induced NP.

Keywords: alpha lipoic acid, multiple sclerosis, neuropathic pain



Corresponding Author: Fazıl Kulaklı, Türkiye

Quick Search




LookUs & Online Makale